The Ontario Pharmacy Evidence Network Atlas of Smoking Cessation Services

No abstract available.

Information

Citation

Rzepka AM, Wong L, Chaudhry M, Sproule BA, He N, Cadarette SM. Can Pharm J (Ott). 2022; 155(4):194-9. Epub 2022 Jun 20.

View Source

Discover More

Journal Article

02/12/2025

Hospital-based care for hallucinogens and risk of mania and bipolar disorder: a population-based cohort study

Myran DT, MacDonald-Spracklin R, Pugliese M, Gibb M, Fiedorowicz JG, Kaster TS, Solmi M. PLoS Med. 2025; 22(12): e1004805.

Journal Article

02/12/2025

Severity of alcohol-related hospitalizations following the onset of the COVID-19 pandemic: a population-based cohort study

Yaseen W, Zagorski B, Li P, Redelmeier DA, Zipursky JS. J Gen Intern Med. 2025; Dec 2 [Epub ahead of print].

Journal Article

26/11/2025

Characteristics of individuals who received a complete, 2-dose mpox vaccine regimen as part of the public health response to the mpox epidemic in Ontario, Canada

Grewal R, Lau C, Kwong JC, Burchell AN, Friedman L, Navarro C, Okpokoro E, Tan DHS, Zygmunt A, Bai L, Mishra S, Buchan SA; Canadian Immunization Research Network (CIRN) Investigators. PLOS Glob Public Health. 2025; 5(11):e0005452.

See All

The Ontario Pharmacy Evidence Network Atlas of Smoking Cessation Services

Information

Citation

Contributing ICES Scientists

Research Programs

Associated Sites

Discover More

Hospital-based care for hallucinogens and risk of mania and bipolar disorder: a population-based cohort study

Severity of alcohol-related hospitalizations following the onset of the COVID-19 pandemic: a population-based cohort study

Characteristics of individuals who received a complete, 2-dose mpox vaccine regimen as part of the public health response to the mpox epidemic in Ontario, Canada